Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer's Disease

Jacqueline A. Bonds; Peter C. Hart; Richard D. Minshall; Orly Lazarov; Jacob M. Haus; Marcelo G. Bonini

doi:10.1016/B978-0-12-802851-3.00013-9

Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer's Disease

Jacqueline A. Bonds^*, Peter C. Hart, Richard D. Minshall, Orly Lazarov, Jacob M. Haus, Marcelo G. Bonini

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter

2 Scopus citations

Abstract

Type 2 diabetes mellitus (T2DM) is an acknowledged risk factor for the development of Alzheimer's disease (AD). However, molecular mechanisms linking these disorders remain poorly defined. This chapter will review recent advancements in the understanding of the etiologic causes of AD occurring in a subgroup of diabetic patients based on studies using a variety of animal models of insulin resistance, and T2DM. We will also focus on vascular deterioration and defective insulin signaling in the brain as primary causes of molecular, vascular, and neuronal changes that translate into cognitive decline, memory loss, and other features characteristic of AD.

Original language	English (US)
Title of host publication	Genes, Environment and Alzheimer's Disease
Publisher	Elsevier Inc
Pages	387-413
Number of pages	27
ISBN (Print)	9780128028513
DOIs	https://doi.org/10.1016/B978-0-12-802851-3.00013-9
State	Published - 2016
Externally published	Yes

Keywords

Diabetes
Endothelial cells
Inflammation
Insulin
Interleukin
Tumor necrosis factor
Vasculature

ASJC Scopus subject areas

Medicine(all)
Neuroscience(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-12-802851-3.00013-9

Cite this

@inbook{d998125c46df42bfb3fcab92a59bcdc4,

title = "Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer's Disease",

abstract = "Type 2 diabetes mellitus (T2DM) is an acknowledged risk factor for the development of Alzheimer's disease (AD). However, molecular mechanisms linking these disorders remain poorly defined. This chapter will review recent advancements in the understanding of the etiologic causes of AD occurring in a subgroup of diabetic patients based on studies using a variety of animal models of insulin resistance, and T2DM. We will also focus on vascular deterioration and defective insulin signaling in the brain as primary causes of molecular, vascular, and neuronal changes that translate into cognitive decline, memory loss, and other features characteristic of AD.",

keywords = "Diabetes, Endothelial cells, Inflammation, Insulin, Interleukin, Tumor necrosis factor, Vasculature",

author = "Bonds, {Jacqueline A.} and Hart, {Peter C.} and Minshall, {Richard D.} and Orly Lazarov and Haus, {Jacob M.} and Bonini, {Marcelo G.}",

year = "2016",

doi = "10.1016/B978-0-12-802851-3.00013-9",

language = "English (US)",

isbn = "9780128028513",

pages = "387--413",

booktitle = "Genes, Environment and Alzheimer's Disease",

publisher = "Elsevier Inc",

}

TY - CHAP

T1 - Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer's Disease

AU - Bonds, Jacqueline A.

AU - Hart, Peter C.

AU - Minshall, Richard D.

AU - Lazarov, Orly

AU - Haus, Jacob M.

AU - Bonini, Marcelo G.

PY - 2016

Y1 - 2016

N2 - Type 2 diabetes mellitus (T2DM) is an acknowledged risk factor for the development of Alzheimer's disease (AD). However, molecular mechanisms linking these disorders remain poorly defined. This chapter will review recent advancements in the understanding of the etiologic causes of AD occurring in a subgroup of diabetic patients based on studies using a variety of animal models of insulin resistance, and T2DM. We will also focus on vascular deterioration and defective insulin signaling in the brain as primary causes of molecular, vascular, and neuronal changes that translate into cognitive decline, memory loss, and other features characteristic of AD.

AB - Type 2 diabetes mellitus (T2DM) is an acknowledged risk factor for the development of Alzheimer's disease (AD). However, molecular mechanisms linking these disorders remain poorly defined. This chapter will review recent advancements in the understanding of the etiologic causes of AD occurring in a subgroup of diabetic patients based on studies using a variety of animal models of insulin resistance, and T2DM. We will also focus on vascular deterioration and defective insulin signaling in the brain as primary causes of molecular, vascular, and neuronal changes that translate into cognitive decline, memory loss, and other features characteristic of AD.

KW - Diabetes

KW - Endothelial cells

KW - Inflammation

KW - Insulin

KW - Interleukin

KW - Tumor necrosis factor

KW - Vasculature

UR - http://www.scopus.com/inward/record.url?scp=84966781574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966781574&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-802851-3.00013-9

DO - 10.1016/B978-0-12-802851-3.00013-9

M3 - Chapter

AN - SCOPUS:84966781574

SN - 9780128028513

SP - 387

EP - 413

BT - Genes, Environment and Alzheimer's Disease

PB - Elsevier Inc

ER -

Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer's Disease

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this